About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 52 record(s)
Req # A-2014-000213
“2013-14 records identifying legal drugs that led to 10 or more deaths in Canada & 100 or more serious ADR’s in Canada. 2013-14 drug safety review reports that are unavailable online. List of all drug safety reviews done to date. 2013-14 list of drugs removed and recalled from the CDN market.”Organization: Health Canada
September 2020
Req # A-2015-000361
All Health Canada reviewer reports and notes related to the New Drug Submission for Saxenda® (liraglutide) (DIN 02437899).Organization: Health Canada
September 2020
Req # A-2016-000929
Copy of the current Risk Management Plan for Humira.Organization: Health Canada
September 2020
Req # A-2020-000794
Requesting the rates of male babies and female babies born as a result of fertility treatments, by fertility treatment, for each fertility clinic in Ontario over the last 10 years.Organization: Health Canada
September 2020
Req # A-2017-001207
Records between Rosa Foods Inc. and Health Canada in relation to the product's classification, marketing and the decision to ban the sale of Soylent products within Canada. Records within Health Canada relating to Rosa Labs, Inc. and the recent decision to ban the Soylent product. Aug 2017 - Nov 2017.Organization: Health Canada
September 2020
Req # A-2019-000403
Letters from Health Canada to all applicant companies regarding any abbreviated new drug submissions (ANDSs) made since October 1, 2019 for Azacitadine.Organization: Health Canada
September 2020
Req # A-2019-000762
All material pertaining to authorizing/approving, the re-organization of the Policy and Regulatory Strategies Directorate of the Regulatory Operations and Enforcement Branch that took place beginning in approximately March 2019 up to 19 August 2019.Organization: Health Canada
September 2020
Req # A-2019-000772
Copies of all Health Canada approved product labelling for Combogesic (Drug Identification Number 02488280), including labelling materials filed and approved in both text and mock-up format. All correspondence between AFT Pharmaceuticals Limited and Health Canada relating to said labelling materials.Organization: Health Canada
September 2020
Req # A-2019-001221
The complete list of authorised research licence under the Cannabis Act as of 09 Oct 2019. Including any research licence authorised as a subclass at a single site.Organization: Health Canada
September 2020
Req # A-2020-000439
Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_03075806.Organization: Health Canada
September 2020